• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine.

作者信息

Salem Fadi, Rein Joshua L, Yu Samuel Mon-Wei, Abramson Mathew, Cravedi Paolo, Chung Miriam

机构信息

Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

出版信息

Kidney Int Rep. 2021 Sep;6(9):2523-2524. doi: 10.1016/j.ekir.2021.07.017. Epub 2021 Jul 27.

DOI:10.1016/j.ekir.2021.07.017
PMID:34337193
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8313814/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ee/8419123/2ad0baec8e8d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ee/8419123/2ad0baec8e8d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19ee/8419123/2ad0baec8e8d/gr1.jpg

相似文献

1
Report of Three Cases of Minimal Change Disease Following the Second Dose of mRNA SARS-CoV-2 COVID-19 Vaccine.第二剂mRNA SARS-CoV-2新冠疫苗接种后发生微小病变病三例报告
Kidney Int Rep. 2021 Sep;6(9):2523-2524. doi: 10.1016/j.ekir.2021.07.017. Epub 2021 Jul 27.
2
A de novo case of minimal change disease following the first dose of the Moderna mRNA-1273 SARS-CoV-2 vaccine without relapse after the second dose.首例在接种 Moderna mRNA-1273 新型冠状病毒疫苗第一针后出现微小病变性肾病，第二针后无复发。
CEN Case Rep. 2022 Nov;11(4):477-481. doi: 10.1007/s13730-022-00702-5. Epub 2022 Apr 18.
3
Exacerbation of Minimal Change Disease Following mRNA COVID-19 Vaccination.mRNA COVID-19 疫苗接种后微小病变病恶化。
Am J Case Rep. 2023 Nov 9;24:e941621. doi: 10.12659/AJCR.941621.
4
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.在 COVID 症状研究应用程序的英国用户中，疫苗接种后 SARS-CoV-2 感染的风险因素和疾病特征：一项前瞻性、基于社区的、嵌套的病例对照研究。
Lancet Infect Dis. 2022 Jan;22(1):43-55. doi: 10.1016/S1473-3099(21)00460-6. Epub 2021 Sep 1.
5
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.分析新加坡成年人接种 2 剂 mRNA COVID-19 或灭活 SARS-CoV-2 疫苗以及接种加强针后的 COVID-19 发病率和严重程度。
JAMA Netw Open. 2022 Aug 1;5(8):e2228900. doi: 10.1001/jamanetworkopen.2022.28900.
6
Association between history of SARS-CoV-2 infection and severe systemic adverse events after mRNA COVID-19 vaccination among U.S. adults.美国成年人中，既往感染 SARS-CoV-2 与 mRNA COVID-19 疫苗接种后严重全身不良事件的相关性。
Vaccine. 2022 Dec 12;40(52):7653-7659. doi: 10.1016/j.vaccine.2022.10.073. Epub 2022 Nov 1.
7
De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor.一名活体肾供者接种辉瑞/生物科技公司的SARS-CoV-2疫苗后发生的新发微小病变病
Medicina (Kaunas). 2021 Dec 27;58(1):37. doi: 10.3390/medicina58010037.
8
Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex.COVID-19 疫苗序贯接种与 SARS-CoV-2 感染后心肌炎发病风险：按年龄和性别分层。
Circulation. 2022 Sep 6;146(10):743-754. doi: 10.1161/CIRCULATIONAHA.122.059970. Epub 2022 Aug 22.
9
Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.真实世界中衰弱老年人接受延长间隔和异源 COVID-19 mRNA 疫苗接种后的血清学反应（UNCoVER）：一项前瞻性观察队列研究的中期报告。
Lancet Healthy Longev. 2022 Mar;3(3):e166-e175. doi: 10.1016/S2666-7568(22)00012-5. Epub 2022 Feb 23.
10
Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients.日本肾移植受者接种第二剂SARS-CoV-2 mRNA疫苗后的长期体液免疫反应
Front Microbiol. 2022 Jun 9;13:922042. doi: 10.3389/fmicb.2022.922042. eCollection 2022.

引用本文的文献

1
Ascertaining the mechanistic etiology of COVID-associated glomerulonephritis: a systematic review.确定新冠相关肾小球肾炎的机制性病因：一项系统综述
Front Med (Lausanne). 2025 Jun 9;12:1568943. doi: 10.3389/fmed.2025.1568943. eCollection 2025.
2
Minimal change disease following COVID-19 vaccination: A systematic review.接种 COVID-19 疫苗后出现微小病变病：系统评价。
PLoS One. 2024 Mar 5;19(3):e0297568. doi: 10.1371/journal.pone.0297568. eCollection 2024.
3
Tip Lesion Most Frequent FSGS Variant Related to COVID-19 Vaccine: Two Case Reports and Literature Review.

本文引用的文献

1
De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?新冠病毒疫苗接种后的新发和复发性肾小球疾病：我们目前了解多少？
Am J Kidney Dis. 2021 Oct;78(4):477-480. doi: 10.1053/j.ajkd.2021.06.004. Epub 2021 Jun 25.
2
Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine.阿斯利康新冠疫苗接种后微小病变病复发
Kidney Int. 2021 Aug;100(2):459. doi: 10.1016/j.kint.2021.06.005. Epub 2021 Jun 10.
3
Letter regarding "Minimal change disease relapse following SARS-CoV-2 mRNA vaccine".
尖端病变：与新冠疫苗相关的最常见局灶节段性肾小球硬化变体：两例病例报告及文献综述
Vaccines (Basel). 2024 Jan 8;12(1):62. doi: 10.3390/vaccines12010062.
4
Viral Glomerulopathy.病毒性肾小球病
Glomerular Dis. 2023 Aug 8;3(1):148-154. doi: 10.1159/000531434. eCollection 2023 Jan-Dec.
5
New-onset minimal change disease following the Moderna COVID-19 vaccine.接种 Moderna COVID-19 疫苗后出现新发微小病变性肾病。
BMJ Case Rep. 2023 Sep 15;16(9):e255144. doi: 10.1136/bcr-2023-255144.
6
Relapse of minimal change disease following the third mRNA COVID-19 vaccination: a case report and literature review.第三次 mRNA COVID-19 疫苗接种后微小病变病复发：病例报告及文献复习。
CEN Case Rep. 2024 Feb;13(1):53-58. doi: 10.1007/s13730-023-00798-3. Epub 2023 May 27.
7
Minimal Change Nephrotic Syndrome with Acute Kidney Injury after the Administration of Pfizer-BioNTech COVID-19 Vaccine.接种辉瑞-生物科技公司新冠疫苗后发生急性肾损伤的微小病变型肾病综合征
Case Rep Infect Dis. 2023 Feb 22;2023:5122228. doi: 10.1155/2023/5122228. eCollection 2023.
8
Minimal change disease (MCD) following vaccination with ChAdOx1 nCoV-19 vaccine in a young Indian male: A case report.一名年轻印度男性接种ChAdOx1 nCoV-19疫苗后发生的微小病变肾病（MCD）：病例报告
J Family Med Prim Care. 2022 Oct;11(10):6568-6570. doi: 10.4103/jfmpc.jfmpc_1082_22. Epub 2022 Oct 31.
9
Vaccines and nephrotic syndrome: efficacy and safety.疫苗与肾病综合征：疗效与安全性。
Pediatr Nephrol. 2023 Sep;38(9):2915-2928. doi: 10.1007/s00467-022-05835-4. Epub 2022 Dec 13.
10
Renal Side Effects of COVID-19 Vaccination.新冠疫苗接种的肾脏副作用
Vaccines (Basel). 2022 Oct 23;10(11):1783. doi: 10.3390/vaccines10111783.
关于“新型冠状病毒mRNA疫苗接种后微小病变病复发”的信函
Kidney Int. 2021 Aug;100(2):458-459. doi: 10.1016/j.kint.2021.05.006. Epub 2021 May 27.
4
Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine.辉瑞-生物科技公司新冠疫苗接种后出现的微小病变性肾病和急性肾损伤。
Kidney Int. 2021 Aug;100(2):461-463. doi: 10.1016/j.kint.2021.04.035. Epub 2021 May 15.